• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

The 23-Valent Pneumoccocal (Pneumovax) Vaccine: For Which Patients?

Poll

For which of these patients would you give the 23-valent pneumoccocal vaccine?

Which of the following should get the 23-valent pneumoccocal (Pneumovax) vaccine per the Advisory Committee on Immunization Practices (ACIP) guidelines?

19-year-old who smokes a pack a day
16-year-old with diabetes mellitus
70-year-old who previously received a dose at age 64
All of the above
Related Videos
Infectious disease specialist talks about COVID-19 vaccine development
COVID 19 impact on healthcare provider mental health
Physician mental health expert discusses impact of COVID-19 on health care workers
Related Content
Tsuboya

ACIP Recommends 2nd COVID-19 Shot for Older Adults, Immunocompromised Individuals

Sydney Jennings
October 24th 2024
Article

CDC Director Mandy Cohen endorsed the ACIP's recommendations, which also call for flexible dosing under shared clinical decision making.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

Pfizer-BioNTech COVID-19 Vaccine May Reduce Risk of Long COVID in Older Adults / Image credit: ©Tobias Arhelger/AdobeStock

Pfizer-BioNTech COVID-19 Vaccine May Reduce Risk of Long COVID in Older Adults

Sydney Jennings
October 21st 2024
Article

IDWeek 2024: Older adults vaccinated with BNT162b2 (Comirnaty) had approximately half the odds of developing long COVID vs unvaccinated adults, according to new data.

Primary Viewpoints Episode 11: AAFP President-elect Discusses Greatest Concerns about Upcoming Flu Season

Primary Viewpoints Episode 11: AAFP President-elect Discusses Greatest Concerns about Upcoming Flu Season

Sydney Jennings
September 13th 2021
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with incoming AAFP president Sterling Ransone, MD.

Pertussis Cases Increasing in US: Daily Dose / image credit: ©New Africa/AdobeStock

Pertussis Cases Increasing in US: Daily Dose

Sydney Jennings
October 17th 2024
Article

Your daily dose of the clinical news you may have missed.

Remdesivir Plus Dexamethasone Reduces Mortality Risk among Adults Hospitalized with COVID-19

Remdesivir Plus Dexamethasone Reduces Mortality Risk among Adults Hospitalized with COVID-19

Sydney Jennings
October 10th 2024
Article

Remdesivir plus dexamethasone was associated with reduced 14- and 28-day mortality vs dexamethasone alone, according to a large study of adults hospitalized with COVID-19.

© 2024 MJH Life Sciences

All rights reserved.